Miniaturized proteins: the backbone cyclic proteinomimetic approach

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Drug Design

Background:

• Proteinomimetics uses peptide-based molecules to mimic native protein functions.
• Proteins and peptides often have pharmacological drawbacks in drug design.
• Mimicking protein active sites with small molecules is a key challenge.

Purpose of the Study:

• To present a novel general method for mimicking proteins using small cyclic peptides.
• To demonstrate the applicability of this method for drug design using bovine pancreatic trypsin inhibitor (BPTI) as a model.
• To overcome pharmacological limitations associated with native proteins and peptides.

Main Methods:

• Developed the backbone cyclic (BC) proteinomimetic approach.
• Combined backbone cyclization of peptides with a selection method called cycloscan.
• Prepared a bicyclic nonapeptide designed to mimic the binding region of BPTI.

Main Results:

• The bicyclic nonapeptide successfully mimicked the binding region of BPTI.
• X-ray crystallography and kinetic studies confirmed similar binding of the mimetic to trypsin as BPTI.
• Inhibition studies indicated that backbone cyclization induced the critical binding conformation.

Conclusions:

• The backbone cyclic (BC) proteinomimetic approach is a viable strategy for designing peptide-based drugs.
• This method can create cyclic peptides that mimic protein functions and overcome pharmacological challenges.
• The study provides a structural and kinetic basis for the efficacy of BPTI mimetic.